MADISON, Wis. (AP) - Wisconsin’s Chippewa tribes have asked a federal appeals court to allow tribal hunters to shoot deer at night.
The Chippewa have been pushing for decades to hunt deer at night in northern Wisconsin’s ceded territory even though the state has banned the practice out of safety concerns. Two years ago the tribes mounted another attempt, arguing the state has allowed night hunting to cull deer and slow chronic wasting disease.
Crabb rejected the tribes’ arguments in December. The tribes filed notice in January they intended to appeal. They submitted a brief Monday with the 7th Circuit Court of Appeals, arguing night hunting has become more common and the state can’t argue it’s unsafe.
State wildlife officials referred questions to the state Department of Justice. A DOJ spokeswoman declined comment.
WASHINGTON (AP) - The Food and Drug Administration is weighing the benefits and risks of two experimental colon cancer screening tests which use DNA from a patient’s stool to detect dangerous tumors and growths.
FDA scientists have questions about the accuracy and the potential real-world impact of the kits from Epigenomics and Exact Sciences, according to briefing documents posted online Monday. The agency released its reviews of the tests ahead of a two-day meeting that starts Wednesday.
Doctors have long used stool tests to look for hidden blood that can be a warning sign of tumors and precancerous polyps. Colon cancer is usually treatable if growths are detected and removed before they multiply and spread to other parts of the body.
Both tests under review were more accurate at detecting tumors and worrisome growths than traditional blood stool tests. However, both tests also returned more false positives - reporting growths when none were actually present.
In addition, the tests were less accurate in patients of certain racial and ethnic groups, including African-Americans. The FDA will ask a panel of experts whether the tests should have special warnings for those patients, among on other questions, at its meeting later this week. The agency is not required to follow such expert advice.
Colorectal cancer is the second leading cause of cancer death in the U.S., with over 50,000 deaths expected this year, according to the American Cancer Society. Deaths from the disease have been declining for more than two decades, a development attributed to increased screening in patients ages 50 to 75. Still, only about 60 percent of people in that age group have had recommended screenings.
Colonoscopy is the most accurate test but many adults are reluctant to undergo the invasive procedure, which requires several hours under sedation as doctors probe the colon with a camera-fitted catheter. Guidelines